December 14, 2018

Thornton Law Firm Notifies Shareholders Of Johnson & Johnson (JNJ) Of An Investigation Involving Possible Securities Fraud Related To Nondisclosure Of Asbestos In J&J Powder Products

By: Guillaume Buell, Esq.

Published December 14, 2018

Thornton Law Firm LLP is investigating potential violations of the federal securities laws on behalf of purchasers of the securities of Johnson & Johnson (NYSE ticker: JNJ) regarding recent revelations that J&J knew about asbestos in its baby powder and talcum powder products dating back several decades. Shareholders who purchased or acquired Johnson & Johnson (JNJ) securities, including common stock, may have a claim to recover losses against J&J based on recent revelations concerning asbestos in its baby powder and talcum powder products.

If you purchased Johnson & Johnson stock, ticker JNJ, you may have a claim for damages. Contact Thornton Law Firm’s shareholder attorneys immediately at shareholder@tenlaw.com or at (617) 720-1333, or toll-free at 1-800-431-4600.

We will respond immediately to your inquiry and diligently assist you in investigating whether J&J committed securities fraud, and determine if you are eligible to recover.

According to media reports, including Reuters, alleged J&J internal documents suggest the Company and its executives have known for decades that its baby powder or talcum powder products caused cancer and contained asbestos. Johnson & Johnson asbestos allegations are the focus of this potential lawsuit.

Thornton Law Firm’s securities attorneys specialize in representing individual shareholders and institutional investors in recovering damages caused by corporate fraud. Its attorneys have decades of experience litigating securities fraud cases in courts throughout the country and have a proven track record of recovering losses on behalf of shareholders. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. Prior results do not guarantee any future outcome.